Assessment of In-Hospital Mortality and Its Risk Factors in Patients with Myocardial Infarction Considering the Logistical Aspects of the Treatment Process—A Single-Center, Retrospective, Observational Study

Technological progress, such as the launching of a new generation of drug-coated stents as well as new antiplatelet drugs, has resulted in the treatment of myocardial infarction (MI) becoming much more effective. The aim of this study was to assess in-hospital mortality and to conduct an assessment of risk factors relevant to the in-hospital death of patients with MI. This study was based on an observational hospital registry of patients with MI (ACS GRU registry). For the purpose of the statistical analysis of the risk factors of death, a univariate logistic regression model was applied. In-hospital general mortality amounted to 7.27%. A higher death risk was confirmed in the following cases: (1) serious adverse events (SAEs) that occurred during the procedure; (2) patients transferred from another department of a hospital (OR = 2.647, p = 0.0056); (3) primary percutaneous coronary angioplasty performed on weekdays between 10 p.m. and 8 a.m. (OR = 2.540, p = 0.0146). The influence of workload and operator experience on the risk of death in a patient with MI has not been confirmed. The results of this study indicate the increasing importance of new risk factors for in-hospital death in patients with MI, such as selected logistical aspects of the MI treatment process and individual SAEs.

[1]  Lukasz Gawinski,et al.  Practical Aspects of the Use of Telematic Systems in the Diagnosis of Acute Coronary Syndrome in Poland , 2022, Medicina.

[2]  G. Sinagra,et al.  [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.

[3]  Xiao-Ce Dai,et al.  Association Between Out-of-Hour Admission and Short- and Long-Term Mortality in Acute Myocardial Infarction: A Systematic Review and Meta-Analysis , 2021, Frontiers in Cardiovascular Medicine.

[4]  P. Engelseth,et al.  Application of Modern Clinical Risk Scores in the Global Assessment of Risks Related to the Diagnosis and Treatment of Acute Coronary Syndromes in Everyday Medical Practice , 2021, International journal of environmental research and public health.

[5]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[6]  Yan Li,et al.  The Clinical and Angiographic Outcomes of Postdilation after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: A Systematic Review and Meta-Analysis , 2021, Journal of interventional cardiology.

[7]  F. Gragnano,et al.  Myocardial Infarction with and without ST-segment Elevation: a Contemporary Reappraisal of Similarities and Differences , 2020, Current cardiology reviews.

[8]  Lukasz Gawinski,et al.  Telematic Support of Management Processes in Diagnosis and Treatment of Acute Myocardial Infarction in Poland , 2020 .

[9]  Lukasz Gawinski,et al.  Management of Processes of the Diagnosis and Treatment of Acute Myocardial Infarction Using Telematics Systems , 2020 .

[10]  Deepak L. Bhatt,et al.  2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2020, European heart journal.

[11]  M. Salarifar,et al.  Short‐term safety and long‐term benefits of stent postdilation after primary percutaneous coronary intervention: Results of a cohort study , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[12]  Umesh M Pai,et al.  In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario , 2019, The Egyptian Heart Journal.

[13]  K. Fox,et al.  Association between time of hospitalization with acute myocardial infarction and in-hospital mortality , 2019, European heart journal.

[14]  Eric J Velazquez,et al.  Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. , 2019, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[15]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  Kristian Thygesen,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.

[17]  E. Bramucci,et al.  Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial , 2018, The Lancet.

[18]  P. Armstrong,et al.  Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study. , 2018, International journal of cardiology.

[19]  Panos Vardas,et al.  European Society of Cardiology: Cardiovascular Disease Statistics 2017. , 2018, European heart journal.

[20]  Marco Valgimigli,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[21]  Sunil V. Rao,et al.  Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States. , 2017, Journal of the American College of Cardiology.

[22]  R. Cruz Ferreira,et al.  ProACS risk score: An early and simple score for risk stratification of patients with acute coronary syndromes. , 2017, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[23]  R. Kiss,et al.  A novel risk model including vascular access site for predicting 30-day mortality after primary PCI: The ALPHA score. , 2017, Cardiovascular revascularization medicine : including molecular interventions.

[24]  Sunil V. Rao,et al.  Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials. , 2016, JACC. Cardiovascular interventions.

[25]  J. Shalhoub,et al.  Trends in Mortality From Ischemic Heart Disease and Cerebrovascular Disease in Europe: 1980 to 2009 , 2016, Circulation.

[26]  Baris Gencer,et al.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2011 .

[27]  E. Braunwald The ten advances that have defined modern cardiology. , 2014, Trends in cardiovascular medicine.

[28]  G. Stone,et al.  Coronary artery calcification: pathogenesis and prognostic implications. , 2014, Journal of the American College of Cardiology.

[29]  G. Stone,et al.  Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. , 2013, International journal of cardiology.

[30]  M. Matheny,et al.  Risk‐Treatment Paradox in the Selection of Transradial Access for Percutaneous Coronary Intervention , 2013, Journal of the American Heart Association.

[31]  S. Kurz,et al.  Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. , 2012, The American journal of medicine.

[32]  A. Alsheikh-Ali,et al.  Impact of Anemia on In-Hospital, One-Month and One-Year Mortality in Patients with Acute Coronary Syndrome from the Middle East , 2012, Clinical Medicine & Research.

[33]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[34]  P. Serruys,et al.  EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention. , 2011, European heart journal.

[35]  C. Terkelsen,et al.  System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. , 2010, JAMA.

[36]  Claes Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[37]  F. Verheugt,et al.  Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. , 2009, Journal of the American College of Cardiology.

[38]  Adnan Kastrati,et al.  Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. , 2009, Journal of the American College of Cardiology.

[39]  E. Antman,et al.  Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.

[40]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[41]  R. Kornowski,et al.  The impact of circadian variation on outcomes in emergency acute anterior myocardial infarction percutaneous coronary intervention , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[42]  J. Ottervanger,et al.  Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. , 2005, American heart journal.

[43]  T. Brennan,et al.  Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I* , 2004, Quality and Safety in Health Care.

[44]  Á. Avezum,et al.  Predictors of hospital mortality in the global registry of acute coronary events. , 2003, Archives of internal medicine.

[45]  H. Gerstein,et al.  Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.

[46]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[47]  M. Funk,et al.  Predicting hospital mortality in patients with acute myocardial infarction. , 1994, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[48]  A. Albert,et al.  Short‐term risk stratification at admission based on simple clinical data in acute myocardial infarction , 1989, The American journal of cardiology.

[49]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.

[50]  P. Brandt,et al.  A new coronary prognostic index. , 1969, American heart journal.

[51]  T. Killip,et al.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. , 1967, The American journal of cardiology.